Reduction in the intensity rate of appropriate shocks for ventricular arrhythmias with statin therapy

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 2, 2010, Pages 190-194

  Beri, Abhimanyu ^a   Contractor, Tahmeed ^a   Gardiner, Joseph C ^b   Ardhanari, Sivakumar ^b   Thakur, Ranjan ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Thoracic and Cardiovascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; DRUG EFFECT; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC DYSFUNCTION;

AGED; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 77955984048     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181e74d4f     Document Type: Article

References (21)

1. Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol. 2004;43:642-648.
2. Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol. 2004;93: 1124-1129.
3. Dickinson M, Ip J, Olshansky B, et al; SCD-HeFT Investigators. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J. 2007;153:573-578.
4. Levantesi G, Scarano M, Marfisi R, et al. Meta-analysis of effect of statin treatment on risk of sudden death. Am J Cardiol. 2007;100:1644-1650.
5. Vyas A, Guo H, Moss A, et al; MADIT-II Research Group. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47: 769-773.
6. De Sutter J, Tavernier R, De Buyzere M, et al. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol. 2000;36:766-772.
7. Chiu J, Abdelhadi R, Chung M, et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol. 2005;95:490-491.
8. Riahi S, Schmidt E, Christensen J, et al. Statins, ventricular arrhythmias and heart rate variability in patients with implantable cardioverter defibrillators and coronary heart disease. Cardiology. 2005;104:210-214.
9. Mitchell L, Powell J, Gillis A, et al; AVID investigators. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiar-rhythmics versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol. 2003;42:81-87.
10. Coleman C, Kluger J, Bhavnani S, et al. Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm. 2008;5:507-510.
11. Goldberger J, Subacius H, Schaechter A, et al; DEFINITE Investigators. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2006;48: 1228-1233.
12. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace. 2005;7:184-192.
13. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc. 2005;80:232-237.
14. Thomas SA, Friedmann E, Kao CW, et al. Quality of life and psychological status of patients with implantable cardioverter defibrilla-tors. Am J Crit Care. 2006;15:389-398.
15. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley; 1989.
16. Cameron AC, Trivedi PK. Microeconomics: Methods and Applications. New York, NY: Cambridge University Press; 2005.
17. Yau KKW, Wang K, Lee AH. Zero-inflated negative binomial mixed regression modeling of over-dispersed count data with extra zeros. Biom J. 2003;45:437-452.
18. Austin PC, Mamdani MM, Stukel TA, et al. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med. 2005;24:1563-1578.
19. Peberdy MA, Ornato JP, Reynolds P, et al; American Heart Association's National Registry of Cardiopulmonary Resuscitation Investigators. The first documented cardiac arrest rhythm in hospitalized patients with heart failure. Resuscitation. 2009;80:1346-1350.
20. Kamphuis HC, de Leeuw JR, Derksen R, et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace. 2003;5:381-389.
21. Guo H. Anti-arrhythmic effects of statins: a hypothesis remains to be tested. Heart Rhythm. 2008;5:511-512.